<DOC>
	<DOCNO>NCT02846675</DOCNO>
	<brief_summary>'s self-control , double blind study autologous adipose-derived stromal vascular fraction ( SVF ) treat 50 osteoarthritic knee grade II III ( K-L scale ) IRB-approved protocol feasibility safety study .</brief_summary>
	<brief_title>Safety Efficacy Autologous SVF Cells Treating Patients With Osteoarthritis</brief_title>
	<detailed_description>The adipose-derived SVF obtain disaggregation lipoaspirate resuspension SVF 2 ml saline , least 50 million nucleated SVF cell mean viability 85 % , inject per single knee knee treat placebo . Cell suspension placebo inject use ultrasound guidance . Safety knee function evaluate questionaires monthly MRI every three month post-op .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Grade II Grade III osteoarthritis use KellgrenLawrence grade scale ( KL Grade ) diagnose use weight bearing Xray , physician review , and/or preop MRI . Study Subjects must fail minimum least two conservative therapy , span period least 3 month . Study Subjects must willing voluntarily give write Informed Consent participate study sign Health Insurance Portability Accountability Act ( HIPAA ) authorization study procedure perform . Subjects good health ( ASA Class III ) BMI &lt; 35 . Subjects must continue pain knee despite conservative therapy least 3 month . Subjects unilateral disease must present symptomatic knee pain use WOMAC subscale pain . Subjects must speak , read understand English . Subjects must reasonably able return multiple followup visit . Females pregnant nursing female childbearing potential unwilling maintain contraceptive therapy duration study . Life expectancy &lt; 6 month due concomitant illness . Exposure investigational drug procedure within 1 month prior study entry enrol concurrent study may confound result study . Active infectious disease . Patients know tested positive HIV , HTLV , HBV , HCV , CMV ( IgM &gt; IgG ) and/or syphilis expert consultation patient eligibility base patient 's infectious status Any illness , Investigator 's judgment , interfere patient 's ability comply protocol , compromise patient safety , interfere interpretation study result Patients chronic immunosuppressive transplant therapy Systolic blood pressure ( supine ) â‰¤90 mm Hg great 180mmHg Resting heart rate &gt; 100 bpm ; Known drug alcohol dependence factor interfere study conduct interpretation result opinion investigator suitable participate . History cancer ( nonmelanoma skin cancer insitu cervical cancer ) last five year . Active clinical infection Unwilling and/or able give write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>SVF</keyword>
	<keyword>Stromal Vascular Fraction</keyword>
	<keyword>osteoarthritis ( OA )</keyword>
	<keyword>knee</keyword>
	<keyword>adipose</keyword>
</DOC>